Investor Brand Network

In a secluded section of the U.S. Drug Enforcement Administration (DEA) headquarters known as the 12th-floor “bubble,” director Anne Milgram called a special “marijuana meeting” in March 2024 where she made an unusual request: no one was allowed to take notes. During the meeting, she informed her top deputies that the Biden administration was about to reschedule cannabis as a less-harmful substance, a significant move toward federal legalization that the... (continue reading...)

GEMXX (OTC: GEMZ), an established mine-to-market gem enterprise, recently announced that it is actively broadening its business framework to incorporate private equity funding for oil and gas (“O&G”) exploration ventures. “With a large network of global relationships and several strategic alliances recently established, GEMXX is setting the stage to finance the exploration of extensive oil reserves, specifically targeting giant fields with reserves of 500 million... (continue reading...)

Biomerica (NASDAQ: BMRA), a biomedical technology company that develops, patents, manufactures and markets advanced diagnostics and therapeutic products, has entered into an at-market issuance sales agreement with EF Hutton LLC and R.F. Lafferty & Co. Inc. According to the company, the agreement is related to BMRA common stock shares. The company filed a prospectus supplement on May 10, 2024. EF Hutton is serving as sales agent to Biomerica in connection with the $5.5... (continue reading...)

Btab Ecommerce Group Inc. (OTC: BBTT), an e-commerce company, has entered into a definitive business combination agreement (“BCA”) with Integrated Wellness Acquisition Corp. (NYSE: WEL), a special purpose acquisition company. According to the announcement, the agreement calls for a wholly owned subsidiary of WEL to merge with BBTT, which will survive the merger, becoming a wholly owned subsidiary of WEL. After the transaction is closed, WEL will be renamed Btab... (continue reading...)

Snap (NYSE: SNAP), under the guidance of CEO Evan Spiegel, is making a bold move by significantly ramping up its investment in artificial intelligence (“AI”) and machine learning technologies, with plans to spend $1.5 billion annually. This strategic decision is a response to the company’s realization that it had lagged in machine learning advancements, which was adversely affecting its business operations. By concentrating its efforts on achieving... (continue reading...)